Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients

Clinical trial NCT03987308 · RECRUITING

Trial details

NCT number: NCT03987308
Sponsor: Beijing Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 2 Diabetic Patients T2DM (Type 2 Diabetes Mellitus)T2DM

Start date: 2019-07-02
Primary completion: 2025-09-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.